The DOLCE/NTI varieties contain less than 0.3% THC, which is why they are classified as industrial hemp in Australia and the United States. In the UK, the THC limit for industrial hemp is 0.2% THC.
In vitro studies at Monash University, Wollongong University and RMIT University have shown that these strains significantly improve the health and viability of neuronal cells and have the ability to reduce inflammation compared to CBD alone, which can be used to treat autism, epilepsy, attention deficit hyperactivity disorder (ADHD), Alzheimer’s disease and other neurological disorders.
Brian Lidman, president of Neurotech, described the results of the study as very encouraging.
…especially the strong anti-inflammatory effects of our strains compared to CBD alone. These results suggest that DOLCE/NTI wires may have wider application in the treatment of a number of neurological disorders. – Lidman – FinFeed
Overall, the study found that the strains reduced the inflammation of brain cells by up to 60%, increased the overall health and viability of brain cells by up to 80% in the absence of toxic attacks, and increased the viability and productivity of mitochondria by up to 60%. According to Neurotech, each of these processes is an important process and outcome for understanding and maintaining brain function and cognitive health.
The Company expects to commence clinical trials in March 2021. Neurotech is listed on the Australian Securities Exchange under the symbol NTI.
TG joined the team in 2014 as news editor and began hosting the podcast in 2016. He lives in upstate New York, where he also teaches media studies at a local university.
phytocannabinoids benefits,cbd brain healing,cannabinoids increase brain cells,best cbd oil for neurological disorders,phytocannabinoids side effects,does cbd affect brain development,cbd rat study,Privacy settings,How Search works,phytocannabinoids effects